ADENOSINE
- Product NDC
- 51662-1631
- 11-digit product format
- 516621631
- Labeler code
- 51662
- Product ID
- 51662-1631_fa6eb0f8-7c42-2e17-e053-6294a90ac8ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ADENOSINE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA078686
- Marketing category
- ANDA
- Marketing start
- 2023-04-28
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| K72T3FS567 | ADENOSINE | 58-61-7 | ADENOSINE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1631-1 | 51662163101 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1) | 2 ml | 2023-04-28 | No | No | Historical |